Gilead Sciences and U.S. Government Settle Billion-Dollar Patent Dispute Over HIV Prevention Drugs
Gilead Sciences Inc. (GILD.O) and the U.S. government have reached a settlement in a high-profile patent dispute involving the pharmaceutical company’s HIV prevention drugs, Truvada and Descovy. Internet Archive Ends…
